Return to Results

Stenting and Angioplasty with Protection in Patients at High-Risk For Endarterectomy-Sapphire WW (Protocol# P06-3603)

new search

Trial Conditions
  • Carotid Artery Disease
What is the purpose of this trial?

Purpose: The primary objective of this study is to assess 30-day outcomes of stenting (any death, stroke or MI) with distal protection in the treatment of obstructive carotid artery disease in high-surgical risk patients with atherosclerotic disease of the carotid artery (ies). Description: The devices to be utilized are the Cordis PRECISE® Nitinol Stent Systems and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewires (ECGW). These devices are approved for commercial use by the Food and Drug Administration (FDA), thus this study is a prospective observational study. Patients will be seen 30 days and phoned 1 year after their index procedure. They will also be followed by Neurology throughout enrollment for stroke status.

Date & Status



Patients who are high-surgical risk patients with atherosclerotic disease of the carotid artery (ies). High surgical risk patients may include, but are not limited to, Congestive Heart Failure, severe pulmonary disease, post radiation treatment, laryngeal palsy, previous carotid Endarterectomy restenosis or³80 years old. Symptomatic patients having cerebrovascular symptoms (TIA, amaurosis fugax, minor or non-disabling stroke) or asymptomatic patients may be eligible.

  • St. Elizabeth's Medical Center - Recruiting
For more information about this trial, contact

Melissa Antonellis
Phone: 617-562-7825

Other Information

Sponsor: Cordis Corporation
Phase: Phase 4
Trial ID: 00369
Volunteers:  Not Accepting Healthy Volunteers

new search

Connect with Steward

Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

Subscribe to our patient e-newsletter

Copyright © 2015 Steward Health Care
Connect Healthcare Panacea CMS Solutions